Medicine & Pharma

Authorities Direct Caution as Woman Hospitalized After Overdosing On CBD and CBG

The patient had been taking six times the recommended dose for the last four months. Experts have warned of the importance of following dosing recommendations, after a rare case in the US saw a woman hospitalised following daily over-consumption of CBD and CBG. A 56-year-old woman in the US was reported to have been hospitalised …

Authorities Direct Caution as Woman Hospitalized After Overdosing On CBD and CBG Read More »

Marijuana Pop-ups Resurfaces In Retail Stores after Fading amid Pandemic

What do tour buses, tarot cards and Mexican wrestling have in common? They’re popping up at medical marijuana dispensaries and adult-use retail shops across the United States. They involve brands – think marijuana producers and edibles makers – setting up temporary venues at stores to promote their products and stand out from the crowd. Pop-ups …

Marijuana Pop-ups Resurfaces In Retail Stores after Fading amid Pandemic Read More »

Economic Challenges May Retain Surge in US Marijuana Stock

The fierce bear market gripping U.S. marijuana stocks looks set to continue – barring a major legislative surprise from the halls of Congress. Publicly traded cannabis companies have seen their stock prices plunge by as much as 70% since early February 2021, largely reflecting the lack of progress in passing some form of legislation to …

Economic Challenges May Retain Surge in US Marijuana Stock Read More »

Neurodivergence & Medical Cannabis Can help Tune Sensory Experiences

Justin Clarke shares how cannabis has helped him find the freedom to enjoy life. My quality of life has improved significantly since starting to use medical cannabis, writes Justin Clarke, who is neurodivergent, in that he is autistic and has ADHD. I consider both my being autistic and ADHD to be linked – this is …

Neurodivergence & Medical Cannabis Can help Tune Sensory Experiences Read More »

US Medical Students Discloses Their Views on Cannabis for Research

A new study has explored the perceptions of cannabis among medical students in the US. New findings suggest medical students in the US have largely positive views on medicinal and recreational cannabis use – but more education is needed. A new study has delved deeper into the perceptions of cannabis among medical students in the …

US Medical Students Discloses Their Views on Cannabis for Research Read More »

Studies Hit Roll-Out Opinion on Cannabinoid Formulations for Parkinson’s

Investigators are taking the first steps towards human trials on a novel formulation of cannabinoids designed to target Parkinson’s disease. Gb Sciences, a US-based research and development company, has announced it will begin dosage studies to test its patent-protected cannabinoid-based formulations, in an animal model of Parkinson’s next month. These studies will determine the dose range …

Studies Hit Roll-Out Opinion on Cannabinoid Formulations for Parkinson’s Read More »

US Brands to Come up With Fresh Trails on CBD for Anxiety Disorders

A US-based pharmaceutical company is set to launch trials exploring how its inhaled CBD products can help treat anxiety disorders. Receptor Life Sciences (RLS), a pharmaceutical company developing new therapies to address central nervous system disorders, has secured funding to study the effects of its CBD formulations on anxiety and mental health conditions. The company announced the …

US Brands to Come up With Fresh Trails on CBD for Anxiety Disorders Read More »

Ontario Cannabis Regulator Set to Permit White-Label Retail Deals.

The cannabis retail regulator in Ontario, Canada, is set to reverse course on its recent decision to ban retailers from creating in-house brands and white-label products, MJBizDaily has learned. The move, if implemented, would allow cannabis stores in Canada’s largest market to continue signing agreements with producers to create such products, according to an email from the …

Ontario Cannabis Regulator Set to Permit White-Label Retail Deals. Read More »

CBN – Can It Become Potential Cure for Glaucoma?

A new study has suggested that the cannabinoid, CBN, shows promise as a potential treatment for glaucoma.  A recently-published study has found that cannabinol (CBN) may be an effective treatment for the eye condition glaucoma. Glaucoma is a common eye condition where the optic nerve, which connects the eye to the brain, becomes damaged. Most cases are caused …

CBN – Can It Become Potential Cure for Glaucoma? Read More »

Cannabotech Products May Kill ‘Over 90% of Colon Cancer Cells’

Biomedical cannabis company, Cannabotech, says its products eliminated “over 90 per cent” of colon cancer cells in early studies.  Cannabotech, which is currently developing cancer products based on cannabis and mushroom extracts, has announced cell model study results, showing that its Integrative-Colon products killed over 90 per cent of cancer cells. The study was conducted by Cannabotech’s …

Cannabotech Products May Kill ‘Over 90% of Colon Cancer Cells’ Read More »